Jan 8, 2024 7:18 am EST CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
Jan 2, 2024 7:00 am EST CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
Nov 29, 2023 7:00 am EST CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Nov 9, 2023 8:00 am EST COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Nov 1, 2023 7:05 am EDT CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
Sep 21, 2023 7:00 am EDT CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
Aug 24, 2023 7:00 am EDT CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
Aug 9, 2023 8:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Jun 26, 2023 7:00 am EDT CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
